Halozyme Therapeutics Inc - Company Profile
Powered by 
All the sales intelligence you need on Halozyme Therapeutics Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Halozyme Therapeutics Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Halozyme Therapeutics Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
The following section provides information on Halozyme Therapeutics Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Halozyme Therapeutics Inc's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Jeffrey W. Henderson
Chairman Executive BoardMr. Jeffrey W. Henderson has been the Chairman of the company since 2022. Prior to this, he served as the President at JWH Consulting LLC. Previously, he served as a Healthcare Advisory Director to Berkshire Partners LLC. Mr. Henderson also served as the Chief Financial Officer of Cardinal Health Inc.
Helen I. Torley
Director; Chief Executive Officer; President Executive BoardDr Helen I. Torley has been the President, Chief Executive Officer, and Director of the company since 2014. Prior to this, she served as the President and Chief Executive Officer of Onyx Pharmaceuticals from 2011 to 2013. Previously, he served as the Vice President and General Manager of US Bone Health and Vice President and General Manager of US Nephrology at Amgen from 2002 to 2011. He served in senior sales and marketing leadership positions at Bristol Myers Squib from 1997 to 2002.
Darren Snellgrove
Chief Financial Officer Senior ManagementMr. Darren Snellgrove has been the Chief Financial Officer of the company since June 2026. Previously, he served as Vice President of Investor Relations at Johnson & Johnson. Prior to this, he was the Chief Financial Officer of the Pharmaceuticals Sector of Johnson & Johnson.
Cortney Caudill
Senior Vice President; Chief Operating Officer Senior ManagementMs. Cortney Caudill has been the Chief Operating Officer of the company since 2023. Prior to this, she served as the Chief Product Officer Aeglea BioTherapeutics. Ms. Caudill also served as the Board Advisor of Ninnion Therapeutics.
Rhys de Callier
Chief Strategy Officer Senior ManagementMr Rhys de Callier has been the Chief Strategy Officer of the company since 2025. Prior to this, he served as the Vice President of Corporate Strategy and Portfolio Management at QuidelOrtho
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer